BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 29863608)

  • 1. Fibrinogen Concentrate in Cardiovascular Surgery: A Meta-analysis of Randomized Controlled Trials.
    Li JY; Gong J; Zhu F; Moodie J; Newitt A; Uruthiramoorthy L; Cheng D; Martin J
    Anesth Analg; 2018 Sep; 127(3):612-621. PubMed ID: 29863608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia.
    Fabes J; Brunskill SJ; Curry N; Doree C; Stanworth SJ
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD010649. PubMed ID: 30582172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen concentrate in bleeding patients.
    Wikkelsø A; Lunde J; Johansen M; Stensballe J; Wetterslev J; Møller AM; Afshari A
    Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD008864. PubMed ID: 23986527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial.
    Rahe-Meyer N; Solomon C; Hanke A; Schmidt DS; Knoerzer D; Hochleitner G; Sørensen B; Hagl C; Pichlmaier M
    Anesthesiology; 2013 Jan; 118(1):40-50. PubMed ID: 23249928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Fibrinogen Concentrate on Intraoperative Blood Loss Among Patients With Intraoperative Bleeding During High-Risk Cardiac Surgery: A Randomized Clinical Trial.
    Bilecen S; de Groot JA; Kalkman CJ; Spanjersberg AJ; Brandon Bravo Bruinsma GJ; Moons KG; Nierich AP
    JAMA; 2017 Feb; 317(7):738-747. PubMed ID: 28241354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double blind trial of prophylactic fibrinogen to reduce bleeding in cardiac surgery.
    Sadeghi M; Atefyekta R; Azimaraghi O; Marashi SM; Aghajani Y; Ghadimi F; Spahn DR; Movafegh A
    Braz J Anesthesiol; 2014; 64(4):253-7. PubMed ID: 24998109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of fibrinogen concentrate on postoperative blood loss: A systematic review and meta-analysis of randomized controlled trials.
    Ng KT; Yap JLL; Kwok PE
    J Clin Anesth; 2020 Aug; 63():109782. PubMed ID: 32193125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen Concentrate as an Alternative to Cryoprecipitate in a Postcardiopulmonary Transfusion Algorithm in Infants Undergoing Cardiac Surgery: A Prospective Randomized Controlled Trial.
    Downey LA; Andrews J; Hedlin H; Kamra K; McKenzie ED; Hanley FL; Williams GD; Guzzetta NA
    Anesth Analg; 2020 Mar; 130(3):740-751. PubMed ID: 31490252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials.
    Wang G; Bainbridge D; Martin J; Cheng D
    Anesth Analg; 2009 Aug; 109(2):320-30. PubMed ID: 19608798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery.
    Ranucci M; Baryshnikova E; Crapelli GB; Rahe-Meyer N; Menicanti L; Frigiola A;
    J Am Heart Assoc; 2015 Jun; 4(6):e002066. PubMed ID: 26037084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of Fibrinogen Concentrate and Cryoprecipitate in Cardiovascular Surgery: Multicenter Database Study.
    Maeda T; Miyata S; Usui A; Nishiwaki K; Tanaka H; Okita Y; Katori N; Shimizu H; Sasaki H; Ohnishi Y; Ueda Y
    J Cardiothorac Vasc Anesth; 2019 Feb; 33(2):321-327. PubMed ID: 30057251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Normovolemic Hemodilution Reduces Allogeneic Red Blood Cell Transfusion in Cardiac Surgery: A Systematic Review and Meta-analysis of Randomized Trials.
    Barile L; Fominskiy E; Di Tomasso N; Alpìzar Castro LE; Landoni G; De Luca M; Bignami E; Sala A; Zangrillo A; Monaco F
    Anesth Analg; 2017 Mar; 124(3):743-752. PubMed ID: 27669554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative beta-blockers for preventing surgery-related mortality and morbidity.
    Blessberger H; Kammler J; Domanovits H; Schlager O; Wildner B; Azar D; Schillinger M; Wiesbauer F; Steinwender C
    Cochrane Database Syst Rev; 2014 Sep; (9):CD004476. PubMed ID: 25233038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogen-reduced platelets for the prevention of bleeding.
    Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen supplementation after cardiac surgery: insights from the Zero-Plasma trial (ZEPLAST).
    Ranucci M; Baryshnikova E
    Br J Anaesth; 2016 May; 116(5):618-23. PubMed ID: 26893405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Fibrinogen Concentrate in Surgical Patients: A Meta-Analysis of Randomized Controlled Trials.
    Fominskiy E; Nepomniashchikh VA; Lomivorotov VV; Monaco F; Vitiello C; Zangrillo A; Landoni G
    J Cardiothorac Vasc Anesth; 2016 Oct; 30(5):1196-204. PubMed ID: 27493092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between fibrinogen levels after cardiopulmonary bypass and large volume red cell transfusion in cardiac surgery: an observational study.
    Karkouti K; Callum J; Crowther MA; McCluskey SA; Pendergrast J; Tait G; Yau TM; Beattie WS
    Anesth Analg; 2013 Jul; 117(1):14-22. PubMed ID: 23687229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial.
    Rahe-Meyer N; Hanke A; Schmidt DS; Hagl C; Pichlmaier M
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3 Suppl):S178-85. PubMed ID: 23410777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.
    Levi M; Cromheecke ME; de Jonge E; Prins MH; de Mol BJ; Briët E; Büller HR
    Lancet; 1999 Dec; 354(9194):1940-7. PubMed ID: 10622296
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.